BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10725716)

  • 1. Large-scale culture and selective maturation of human Langerhans cells from granulocyte colony-stimulating factor-mobilized CD34+ progenitors.
    Gatti E; Velleca MA; Biedermann BC; Ma W; Unternaehrer J; Ebersold MW; Medzhitov R; Pober JS; Mellman I
    J Immunol; 2000 Apr; 164(7):3600-7. PubMed ID: 10725716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale isolation of immature dendritic cells with features of Langerhans cells by sorting CD34+ cord blood stem cells cultured in the presence of TGF-beta1 for cutaneous leukocyte antigen (CLA).
    Bartz H; Rothoeft T; Anhenn O; Bunse D; Schauer U
    J Immunol Methods; 2003 Apr; 275(1-2):137-48. PubMed ID: 12667678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of large numbers of Langerhans' cells with intraepithelial migration ability in vitro.
    Hubert P; Bousarghin L; Greimers R; Franzen-Detrooz E; Boniver J; Delvenne P
    Exp Dermatol; 2005 Jun; 14(6):469-77. PubMed ID: 15885083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation.
    Riedl E; Stöckl J; Majdic O; Scheinecker C; Knapp W; Strobl H
    Blood; 2000 Dec; 96(13):4276-84. PubMed ID: 11110702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking.
    Peiser M; Wanner R; Kolde G
    J Leukoc Biol; 2004 Sep; 76(3):616-22. PubMed ID: 15178702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
    Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
    Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage colony-stimulating factor in cooperation with transforming growth factor-beta1 induces the differentiation of CD34+ hematopoietic progenitor cells into Langerhans cells under serum-free conditions without granulocyte-macrophage colony-stimulating factor.
    Mollah ZU; Aiba S; Nakagawa S; Hara M; Manome H; Mizuashi M; Ohtani T; Yoshino Y; Tagami H
    J Invest Dermatol; 2003 Feb; 120(2):256-65. PubMed ID: 12542531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells.
    Geissmann F; Revy P; Regnault A; Lepelletier Y; Dy M; Brousse N; Amigorena S; Hermine O; Durandy A
    J Immunol; 1999 Apr; 162(8):4567-75. PubMed ID: 10201996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development.
    Woltman AM; Massacrier C; de Fijter JW; Caux C; van Kooten C
    J Immunol; 2002 Jun; 168(12):6181-8. PubMed ID: 12055231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors.
    Caux C; Massacrier C; Dubois B; Valladeau J; Dezutter-Dambuyant C; Durand I; Schmitt D; Saeland S
    J Leukoc Biol; 1999 Nov; 66(5):781-91. PubMed ID: 10577510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cells derived from genetically modified human CD34+ hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responses.
    Yuan J; Latouche JB; Reagan JL; Heller G; Riviere I; Sadelain M; Young JW
    J Immunol; 2005 Jan; 174(2):758-66. PubMed ID: 15634896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis.
    Caux C; Massacrier C; Vanbervliet B; Dubois B; Durand I; Cella M; Lanzavecchia A; Banchereau J
    Blood; 1997 Aug; 90(4):1458-70. PubMed ID: 9269763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
    Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
    Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells.
    Ito T; Inaba M; Inaba K; Toki J; Sogo S; Iguchi T; Adachi Y; Yamaguchi K; Amakawa R; Valladeau J; Saeland S; Fukuhara S; Ikehara S
    J Immunol; 1999 Aug; 163(3):1409-19. PubMed ID: 10415041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro differentiation of CD34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the birbeck granule and MIIC-positive Langerhans cell and the interdigitating dendritic cell type.
    Herbst B; Köhler G; Mackensen A; Veelken H; Kulmburg P; Rosenthal FM; Schaefer HE; Mertelsmann R; Fisch P; Lindemann A
    Blood; 1996 Oct; 88(7):2541-8. PubMed ID: 8839846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineation of the dendritic cell lineage by generating large numbers of Birbeck granule-positive Langerhans cells from human peripheral blood progenitor cells in vitro.
    Mackensen A; Herbst B; Köhler G; Wolff-Vorbeck G; Rosenthal FM; Veelken H; Kulmburg P; Schaefer HE; Mertelsmann R; Lindemann A
    Blood; 1995 Oct; 86(7):2699-707. PubMed ID: 7545468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytosis of co-developing neutrophil progenitors by dendritic cells in a culture of human CD34(+) cells with granulocyte colony-stimulating factor and tumor necrosis factor-alpha.
    Saito Y; Guo YM; Hirokawa M; Saito K; Komatsuda A; Takahashi N; Fujishima M; Fujishima N; Yamashita J; Sawada K
    Int J Hematol; 2008 Jul; 88(1):64-72. PubMed ID: 18484240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells.
    Servet-Delprat C; Vidalain PO; Bausinger H; Manié S; Le Deist F; Azocar O; Hanau D; Fischer A; Rabourdin-Combe C
    J Immunol; 2000 Feb; 164(4):1753-60. PubMed ID: 10657621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursors.
    Curti A; Fogli M; Ratta M; Tura S; Lemoli RM
    J Immunol; 2001 Jan; 166(2):848-54. PubMed ID: 11145659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.
    Siena S; Di Nicola M; Bregni M; Mortarini R; Anichini A; Lombardi L; Ravagnani F; Parmiani G; Gianni AM
    Exp Hematol; 1995 Dec; 23(14):1463-71. PubMed ID: 8542932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.